Tudor Investment Corp’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$202K Buy
2024
Q4
$243K Sell
2024
Q3
$1.15M Buy
2024
Q2
$473K Sell
2024
Q1
$1.13M Buy
2023
Q4
$375K Buy
2023
Q2
Sell
2023
Q1
$754K Buy
2022
Q4
Sell
2022
Q3
$483K Buy
2022
Q2
$337K Buy